Pharmsville Co., Ltd. (KOSDAQ:318010)

Pharmsville Statistics

Total Valuation

Pharmsville has a market cap or net worth of KRW 27.32 billion. The enterprise value is -12.22 billion.

Market Cap	27.32B
Enterprise Value	-12.22B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Pharmsville has 7.73 million shares outstanding. The number of shares has decreased by -0.43% in one year.

Current Share Class	7.73M
Shares Outstanding	7.73M
Shares Change (YoY)	-0.43%
Shares Change (QoQ)	-0.51%
Owned by Insiders (%)	62.88%
Owned by Institutions (%)	n/a
Float	2.01M

Valuation Ratios

The trailing PE ratio is 9.06.

PE Ratio	9.06
Forward PE	n/a
PS Ratio	2.04
PB Ratio	0.41
P/TBV Ratio	0.42
P/FCF Ratio	236.86
P/OCF Ratio	221.71
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.05
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-105.93

Financial Position

The company has a current ratio of 19.34, with a Debt / Equity ratio of 0.00.

Current Ratio	19.34
Quick Ratio	18.56
Debt / Equity	0.00
Debt / EBITDA	0.12
Debt / FCF	0.15
Interest Coverage	-68.35

Financial Efficiency

Return on equity (ROE) is 4.66% and return on invested capital (ROIC) is -0.50%.

Return on Equity (ROE)	4.66%
Return on Assets (ROA)	-0.47%
Return on Invested Capital (ROIC)	-0.50%
Return on Capital Employed (ROCE)	-0.78%
Revenue Per Employee	494.80M
Profits Per Employee	111.61M
Employee Count	27
Asset Turnover	0.19
Inventory Turnover	2.33

Taxes

In the past 12 months, Pharmsville has paid 127.60 million in taxes.

Income Tax	127.60M
Effective Tax Rate	4.05%

Stock Price Statistics

The stock price has decreased by -23.88% in the last 52 weeks. The beta is -0.12, so Pharmsville's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	-23.88%
50-Day Moving Average	3,779.30
200-Day Moving Average	3,806.10
Relative Strength Index (RSI)	44.45
Average Volume (20 Days)	17,205

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmsville had revenue of KRW 13.36 billion and earned 3.01 billion in profits. Earnings per share was 390.21.

Revenue	13.36B
Gross Profit	8.57B
Operating Income	-519.43M
Pretax Income	3.15B
Net Income	3.01B
EBITDA	144.48M
EBIT	-519.43M
Earnings Per Share (EPS)	390.21

Balance Sheet

The company has 39.66 billion in cash and 17.62 million in debt, giving a net cash position of 39.65 billion or 5,130.09 per share.

Cash & Cash Equivalents	39.66B
Total Debt	17.62M
Net Cash	39.65B
Net Cash Per Share	5,130.09
Equity (Book Value)	65.92B
Book Value Per Share	8,532.47
Working Capital	40.19B

Cash Flow

In the last 12 months, operating cash flow was 123.22 million and capital expenditures -7.88 million, giving a free cash flow of 115.34 million.

Operating Cash Flow	123.22M
Capital Expenditures	-7.88M
Free Cash Flow	115.34M
FCF Per Share	14.92

Margins

Gross margin is 64.16%, with operating and profit margins of -3.89% and 22.56%.

Gross Margin	64.16%
Operating Margin	-3.89%
Pretax Margin	23.58%
Profit Margin	22.56%
EBITDA Margin	1.08%
EBIT Margin	-3.89%
FCF Margin	0.86%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.83%.

Dividend Per Share	100.00
Dividend Yield	2.83%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	25.64%
Buyback Yield	0.43%
Shareholder Yield	3.26%
Earnings Yield	11.03%
FCF Yield	0.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmsville has an Altman Z-Score of 9.01 and a Piotroski F-Score of 4.

Altman Z-Score	9.01
Piotroski F-Score	4